Continuous intradialytic amino acid infusion from the start of dialysis is better to avoid catabolism under the high-volume pre-dilution on-line HDF.


Journal

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs
ISSN: 1619-0904
Titre abrégé: J Artif Organs
Pays: Japan
ID NLM: 9815648

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 27 03 2021
accepted: 03 02 2022
pubmed: 1 3 2022
medline: 11 11 2022
entrez: 28 2 2022
Statut: ppublish

Résumé

It was reported that amino acid infusion during hemodialysis is useful for improving nutritional status. The optimal administration method of amino acid infusion under the high-volume pre-dilution on-line HDF (HVPO-HDF) was analyzed in this study. Subjects were 10 patients on maintenance dialysis at our clinic. We performed high-volume pre-dilution on-line HDF. We investigated two methods for administration of Neoamiyu

Identifiants

pubmed: 35226230
doi: 10.1007/s10047-022-01319-2
pii: 10.1007/s10047-022-01319-2
doi:

Substances chimiques

Amino Acids 0
Dialysis Solutions 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

377-381

Informations de copyright

© 2022. The Japanese Society for Artificial Organs.

Références

Nitta K, Goto S, Masakane I, et al. Annual dialysis date report for 2018, JSDT Renal Date Registry: survey methods, facility date, incidence, prevalence, and mortality. Ren Replace Ther. 2020;6:41.
doi: 10.1186/s41100-020-00286-9
Kim JK, Choi SR, Choi MJ, et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr. 2014;33:64–8.
doi: 10.1016/j.clnu.2013.04.002 pubmed: 23631844
Ren H, Gong D, Jia F, et al. Sarcopenia in patients undergoing maintenance hemodialysis: incidence rate, risk factors and its effect on survival risk. Ren Fail. 2016;38:364–71.
doi: 10.3109/0886022X.2015.1132173 pubmed: 26738817
Johansen KL, Chertow GM, Jin C, et al. Significance of frailty among dialysis patients. J Am Soc Nephrol. 2007;18:2960–7.
doi: 10.1681/ASN.2007020221 pubmed: 17942958
Cano NJ, Aparicio M, Brunori G, et al. ESPEN guidelines on parenteral nutrition: adult renal failure. Clin Nutr. 2009;28:401–14.
doi: 10.1016/j.clnu.2009.05.016 pubmed: 19535181
McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N). JPEN J Parenter Enteral Nutr. 2016;40:159–211.
doi: 10.1177/0148607115621863 pubmed: 26773077
Löfberg E, Essén P, McNurlan M, Wernerman J, Garlick P, Anderstam B, et al. Effect of hemodialysis on protein synthesis. Clin Nephrol. 2000;54:284–94.
pubmed: 11076104
Mokrzycki MH, Kaplan AA. Protein losses in continuous renal replacement therapies. J Am Soc Nephrol. 1996;7:2259–63.
doi: 10.1681/ASN.V7102259 pubmed: 8915988
Davies SP, Reaveley DA, Brown EA, Kox WJ. Amino acid clearances and daily losses in patients with acute renal failure treated by continuous arteriovenous hemodialysis. Crit Care Med. 1991;19:1510–5.
doi: 10.1097/00003246-199112000-00012 pubmed: 1959370
Schepky AG, Bensch KW, Schulz-Knappe P, Forssmann WG. Human hemofiltrate as a source of circulating bioactive peptides: determination of amino acids, peptides and proteins. Biomed Chromatogr. 1994;8:90–4.
doi: 10.1002/bmc.1130080209 pubmed: 8044028
Ikizler TA, Pupim LB, Brouillette JR, et al. Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. Am J Physiol Endocrinol Metab. 2002;282:e107–16.
doi: 10.1152/ajpendo.2002.282.1.E107 pubmed: 11739090
Raj DS, Zager P, Shah VO, Dominic EA, Adeniyi O, Blandon P, et al. Protein turnover and amino acid transport kinetics in end-stage renal disease. Am J Physiol Endocrinol Metab. 2004;286:E136–43.
doi: 10.1152/ajpendo.00352.2003 pubmed: 13129859
Yamashita AC, Yoshimoto T, Yoshimoto K, et al. Methodological consideration on measurement of removed solute amount. J Jpn Soc Dial Ther. 1982;15:803–7 (in Japanese).
doi: 10.4009/jsdt1968.15.803
Marsen TA, Beer J, Mann H. Intradialytic parenteral nutrition in maintenance hemodialysis patients suffering from protein-energy wasting. Results of a multicenter, open, prospective, randomized trial. Clin Nutr. 2017;36:107–17.
doi: 10.1016/j.clnu.2015.11.016 pubmed: 26708726
Anderson J, Peterson K, Bourne D, et al. Effectiveness of intradialytic parenteral nutrition in treating protein- energy wasting in hemodialysis: a rapid systematic review. J Ren Nutr. 2019;29:361–9.
doi: 10.1053/j.jrn.2018.11.009 pubmed: 30686749
Isaka Y, Kanno Y, Hanafusa N, et al. Recommendations for parenteral and enteral nutrition in patients on chronic maintenance hemodialysis. J Jpn Soc Dial Ther. 2020;53:373–91 (in Japanese).
Tsubakihara Y, Iida N, Yuasa S, et al. Catabolic stress to nitrogen (N) metabolism and essential amino acid (EAA) supplementation in hemodialysis (HD). Nihon Jinzo Gakkai Shi. 1982;24:1127–36 (in Japanese).
pubmed: 6819373
Urabe S, et al. Amino acid losses are lower during pre-dilution on-line HDF than HD of the same Kt/V for urea. J Artif Organs. 2020;23:342–7.
doi: 10.1007/s10047-020-01174-z pubmed: 32418159

Auteurs

Motoko Kato (M)

Department of Clinical Engineering, Eijin Clinic, 4-5-25, Higashishindo, Hiratsuka, Kanagawa, Japan. mocha148@gmail.com.

Shunichiro Urabe (S)

Department of Clinical Engineering, Eijin Clinic, 4-5-25, Higashishindo, Hiratsuka, Kanagawa, Japan.

Shohei Matsuzawa (S)

Department of Clinical Engineering, Eijin Clinic, 4-5-25, Higashishindo, Hiratsuka, Kanagawa, Japan.

Akira Kato (A)

Department of Clinical Engineering, Eijin Clinic, 4-5-25, Higashishindo, Hiratsuka, Kanagawa, Japan.

Momoko Fukazawa (M)

Department of Clinical Engineering, Eijin Clinic, 4-5-25, Higashishindo, Hiratsuka, Kanagawa, Japan.

Emi Hiyama (E)

Department of Clinical Engineering, Eijin Clinic, 4-5-25, Higashishindo, Hiratsuka, Kanagawa, Japan.

Asami Kurii (A)

Department of Clinical Engineering, Eijin Clinic, 4-5-25, Higashishindo, Hiratsuka, Kanagawa, Japan.

Noriko Mikami (N)

Kurata Hospital, 4-5-26, Higashishindo, Hiratsuka, Kanagawa, Japan.

Yukie Kitajima (Y)

Tokyo Healthcare University, 3-11-3, Setagaya-ku, Tokyo, Japan.

Miho Hida (M)

Kurata Hospital, 4-5-26, Higashishindo, Hiratsuka, Kanagawa, Japan.

Kenichi Kokubo (K)

Kitasato University School of Allied Health Sciences, 1-15-1, Kitasato, Minamiku, Sagamihara, Kanagawa, Japan.

Toru Hyodo (T)

Eijin Clinic, 4-5-25, Higashishindo, Hiratsuka, Kanagawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH